Molecular Therapy · 2020 · 120 citations · 41 references
MedicineOncologyPharmacologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyCancer-associated FibroblastsImmunotherapy For Breast CancerMyeloid-derived Suppressor CellsTargeted Cancer TherapyTumor Microenvironment ModulationCancer-associated Fibroblast TargetingCancer-associated Fibroblast-mediated Immune SuppressionCd8 Positive T CellsChimeric Antigen Receptor T Cell Combination TherapyOlaparib TherapyPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase InhibitionPoly(adp-ribose) Polymerase Inhibitors
41
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Lu Zhang, Jianghao Xu, Xuan Zhang et al. · Cellular Physiology and Biochemistry · 2017 · 4.1K citations · Full text
Medicine, Cancer Biology, Oncology +16
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai et al. · Science Translational Medicine · 2017 · 1.8K citations · Full text
Medicine, Immunology, Oncology +17